Literature DB >> 29251738

NM23 proteins: innocent bystanders or local energy boosters for CFTR?

Richmond Muimo1, Hani Mm Alothaid1, Anil Mehta2.   

Abstract

NM23 proteins NDPK-A and -B bind to the cystic fibrosis (CF) protein CFTR in different ways from kinases such as PKA, CK2 and AMPK or linkers to cell calcium such as calmodulin and annexins. NDPK-A (not -B) interacts with CFTR through reciprocal AMPK binding/control, whereas NDPK-B (not -A) binds directly to CFTR. NDPK-B can activate G proteins without ligand-receptor coupling, so perhaps NDPK-B's binding influences energy supply local to a nucleotide-binding site (NBD1) needed for CFTR to function. Curiously, CFTR (ABC-C7) is a member of the ATP-binding cassette (ABC) protein family that does not obey 'clan rules'; CFTR channels anions and is not a pump, regulates disparate processes, is itself regulated by multiple means and is so pleiotropic that it acts as a hub that orchestrates calcium signaling through its consorts such as calmodulin/annexins. Furthermore, its multiple partners make CFTR dance to different tunes in different cellular and subcellular locations as it recycles from the plasma membrane to endosomes. CFTR function in airway apical membranes is inhibited by smoking which has been dubbed 'acquired CF'. CFTR alone among family members possesses a trap for other proteins that it unfurls as a 'fish-net' and which bears consensus phosphorylation sites for many protein kinases, with PKA being the most canonical. Recently, the site of CFTR's commonest mutation has been proposed as a knock-in mutant that alters allosteric control of kinase CK2 by log orders of activity towards calmodulin and other substrates after CFTR fragmentation. This link from CK2 to calmodulin that binds the R region invokes molecular paths that control lumen formation, which is incomplete in the tracheas of some CF-affected babies. Thus, we are poised to understand the many roles of NDPK-A and -B in CFTR function and, especially lumen formation, which is defective in the gut and lungs of many CF babies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29251738     DOI: 10.1038/labinvest.2017.121

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  108 in total

Review 1.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

2.  Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle.

Authors:  László Csanády; Angus C Nairn; David C Gadsby
Journal:  J Gen Physiol       Date:  2006-10-16       Impact factor: 4.086

3.  Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene.

Authors:  J A Tabcharani; X B Chang; J R Riordan; J W Hanrahan
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

4.  Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.

Authors:  S Zeltwanger; F Wang; G T Wang; K D Gillis; T C Hwang
Journal:  J Gen Physiol       Date:  1999-04       Impact factor: 4.086

Review 5.  Molecular modelling and molecular dynamics of CFTR.

Authors:  Isabelle Callebaut; Brice Hoffmann; Pierre Lehn; Jean-Paul Mornon
Journal:  Cell Mol Life Sci       Date:  2016-10-07       Impact factor: 9.261

6.  The 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex.

Authors:  I Leclerc; A Kahn; B Doiron
Journal:  FEBS Lett       Date:  1998-07-17       Impact factor: 4.124

7.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR.

Authors:  Kate J Treharne; Zhe Xu; Jeng-Haur Chen; O Giles Best; Diane M Cassidy; Dieter C Gruenert; Péter Hegyi; Michael A Gray; David N Sheppard; Karl Kunzelmann; Anil Mehta
Journal:  Cell Physiol Biochem       Date:  2009-11-04

9.  Annexin-1 Mediates Microglial Activation and Migration via the CK2 Pathway during Oxygen-Glucose Deprivation/Reperfusion.

Authors:  Shuangxi Liu; Yan Gao; Xiaoli Yu; Baoming Zhao; Lu Liu; Yin Zhao; Zhenzhao Luo; Jing Shi
Journal:  Int J Mol Sci       Date:  2016-10-22       Impact factor: 5.923

Review 10.  Regulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity.

Authors:  Carlos M Farinha; Agnieszka Swiatecka-Urban; David L Brautigan; Peter Jordan
Journal:  Front Chem       Date:  2016-01-20       Impact factor: 5.221

View more
  2 in total

1.  The NDPK/NME superfamily: state of the art.

Authors:  Mathieu Boissan; Uwe Schlattner; Marie-Lise Lacombe
Journal:  Lab Invest       Date:  2018-02       Impact factor: 5.662

Review 2.  Cystic Fibrosis, CFTR, and Colorectal Cancer.

Authors:  Patricia Scott; Kyle Anderson; Mekhla Singhania; Robert Cormier
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.